Micron Stock Slips 1% After a Volatile Week for Memory Chip Stocks
Mondeum Capital (UK) Limited

Micron shares slipped 1% in early Friday trading after a week of ups and downs. The stock climbed from below $660 to a 4.1% gain on Thursday, but then fell back by Friday morning. This week, the memory chip sector was influenced by remarks from a competitor’s CEO, a narrowly avoided strike at Samsung, and a major manufacturing achievement by Micron. Here’s a look at what happened and what it could mean for the memory chip market next week.
On Friday, Micron said it has started making 1-alpha DRAM at its Virginia plant, calling it the most advanced memory ever made in the United States. The CEO described this as a key part of Micron’s $200 billion plan to grow memory manufacturing and research in the U.S.
The week’s market swings started Monday after Seagate Technology’s CEO told investors that expanding factories to meet storage demand would take too long. This led to a selloff in memory and storage stocks. However, Circular Technologies’ head of research disagreed in a note, saying Seagate’s comments actually suggest a better supply and pricing outlook, since limited capacity could keep memory prices higher.
A strike threat at Samsung that had been growing for weeks ended late Wednesday when management and union leaders agreed on bonus pay just hours before a walkout was set to start. The union put the strike on hold from May 21 to June 7 while members vote through May 27. Even with the deal, Samsung shares dropped 2.3% in Seoul on Friday, which suggests investors had already expected the supply relief.
Recent news

IMAX Stock Jumps 15% on Sale Reports: Who’s Buying?
IMAX is considering a sale, sparking speculation about buyers. Shares rose 15% Friday after the Wall Street Journal reported IMAX approached entertainment companies. The process is early and may not end in a deal. Here are the analysts’ top buyer picks and what each could gain with IMAX. Netflix is attracting the most attention as […]

Merck Shares Jump 4.9% on Cancer Trial Win as Keytruda Patent Cliff Looms
Merck wants to show it is not just a one-drug company, and Friday’s clinical trial results gave it a boost. Shares rose 4.9% in premarket trading after a partner drug worked well in advanced lung cancer when used with Merck’s main cancer treatment. At the same time, European regulators moved closer to approving another Keytruda […]

NVIDIA Shares Edge Up 0.8% as Earnings Beat Makes the Stock Look Even Cheaper
NVIDIA beat earnings expectations, but the stock still slipped. Shares fell 1.8% on Thursday after the report, then bounced back 0.8% in premarket trading Friday. For investors wondering about this muted response, the explanation is pretty straightforward. The stock is now cheaper than before the results, and most of Wall Street remains bullish. Here’s how […]
Trade with fewer limits
Day trade with fewer limits at fast speed. Buy stocks and ETFs at low fees.
Featured Courses